TruBridge (TBRG) Revenue & Revenue Breakdown
TruBridge Revenue Highlights
Latest Revenue (Y)
$339.17K
Latest Revenue (Q)
$86.11M
TruBridge Revenue by Period
TruBridge Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $339.17K | -99.90% |
| 2023-12-31 | $339.44M | 3.91% |
| 2022-12-31 | $326.65M | 16.40% |
| 2021-12-31 | $280.63M | 6.10% |
| 2020-12-31 | $264.49M | -3.69% |
| 2019-12-31 | $274.63M | -2.06% |
| 2018-12-31 | $280.41M | 1.26% |
| 2017-12-31 | $276.93M | 3.61% |
| 2016-12-31 | $267.27M | - |
TruBridge generated $339.17K in revenue during NA 2024, up -99.90% compared to the previous quarter, and up 0.12% compared to the same period a year ago.
TruBridge Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $86.11M | 0.44% |
| 2025-06-30 | $85.73M | -1.70% |
| 2025-03-31 | $87.21M | -4.00% |
| 2024-12-31 | $90.84M | 8.36% |
| 2024-09-30 | $83.83M | -2.07% |
| 2024-06-30 | $85.60M | 1.76% |
| 2024-03-31 | $84.12M | -2.04% |
| 2023-12-31 | $85.87M | 3.82% |
| 2023-09-30 | $82.71M | -2.26% |
| 2023-06-30 | $84.62M | -1.87% |
| 2023-03-31 | $86.23M | 3.62% |
| 2022-12-31 | $83.22M | 0.48% |
| 2022-09-30 | $82.83M | 0.12% |
| 2022-06-30 | $82.73M | 6.23% |
| 2022-03-31 | $77.87M | 5.23% |
| 2021-12-31 | $74.00M | 5.58% |
| 2021-09-30 | $70.09M | 2.27% |
| 2021-06-30 | $68.53M | - |
TruBridge generated $86.11M in revenue during Q3 2025, up 0.44% compared to the previous quarter, and up 100.59% compared to the same period a year ago.
TruBridge Revenue Breakdown
TruBridge Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 24 |
|---|---|
| Acute Care | $54.16M |
| Post Acute Care | $582.00K |
Latest
TruBridge's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Acute Care (98.94%), and Post Acute Care (1.06%).
TruBridge Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| DH | Definitive Healthcare | $252.20M | $60.05M |
| CERS | Cerus | $180.27M | $52.70M |
| LFMD | LifeMD | $158.44M | $47.28M |
| NRC | National Research | $143.06M | $34.61M |
| SPOK | Spok | $137.65M | $33.87M |
| OPRX | OptimizeRx | $92.13M | $26.07M |
| SLP | Simulations Plus | $79.18M | $20.36M |
| SOPH | SOPHiA GENETICS | $62.37M | $15.78M |
| MASS | 908 Devices | $59.63M | $14.01M |
| SENS | Senseonics | $22.47M | $8.10M |
| TBRG | TruBridge | $339.17K | $86.11M |